day 1 agenda
| World Congress on Vaccines July 10-11, 2025 @ Vienna, Austria |
||
| Day-1 (July 10, 2025) | ||
| 08:30-09:30 | Registrations | |
| 09:30-09:45 | Welcome Remarks by Moderator | |
| Keynote Talks | ||
| Liang Zhou, University of Florida, USA | 09:45-10:15 | The role of Innate Lymphoid Cells in Mucosal Infection |
| Nisha J Garg, Washington University, USA | 10:15-10:45 | Subunit nanovaccine elicited T cell functional activation controls Trypanosoma cruzi mediated maternal and placental tissue damage and improves pregnancy outcomes in mice |
| Juraj Ivanyi, Kings College London, UK | 10:45-11:15 | Tuberculosis vaccination needs to avoid ‘decoy’ immune reactions |
| Group Photo & Refreshment Break (11:15-11:35) | ||
| Technical Session-I | ||
| Session Chairs: TBA | ||
| Jooeun Bae, Harvard Medical School, USA | 11:35-12:00 | Combinational Immunotherapy with Multi-antigen targeting Cancer Vaccine |
| Ming-Liang He, City University of Hong Kong, Hong Kong | 12:00-12:20 | Discovery of an inhibitor ligand of IFNAR1: a new mechanism for viruses to escape from cellular innate immunity |
| Lina Souan, King Hussein Cancer Center, Jordan | 12:20-12:40 | Effectiveness and Duration of Anti-RBD SARS-CoV-2 IgG Response Across Vaccines: Implications for Vaccine Strategies |
| Lingbao Kong, Jiangxi Agricultural University, China | 12:40-13:00 | Expression, antiserum preparation and omics analysis of Mpox virus proteins |
| Lunch Break @ Restaurant (13:00-14:00) | ||
| Technical Session-II | ||
| Session Chairs: TBA | ||
| Shin, Yeun-Kyung, Animal and Plant Quarantine Agency, South Korea | 14:00-14:20 | Propagation of porcine reproductive and respiratory syndrome virus increases in PRRSV-susceptible porcine kidney cells modifying LGP2 and RIG-I |
| Yaveenth Sooriyakumar, University College London. UK | 14:20-14:40 | Barriers to the Flu Vaccination: Patients’ Perspective within a London GP |
| Jianyang Du, The University of Tennessee Health Science Center, USA | 14:40-15:00 | The neuroimmune mechanisms underlying SARS-CoV-2-induced post-acute sequelae of COVID-19 |
| Ruth Nielsen, Council of Yukon First Nations & Yukon University, Canada | 15:00-15:20 | Community-based approaches to determining vaccine hesitancy in the Yukon Territory, Canada |
| Pooja Goel, The Lyndhurst Surgery, UK | 15:20-15:40 | Barriers to the Flu Vaccination: Patients’ Perspective within a London GP |
| Ximeng Han, Jenner Institute, University of Oxford, UK | 15:40-16:00 | TBA |
| Refreshment Break (16:00-16:20) | ||
| Min-Hua Luo, Daping Hospital, Army Medical University, China | 16:20-16:40 | Construction and characterization of a synthesized herpes simplex virus H129-Syn-G2 |
| Gandhali Paranjape, DiagnoSearch Life Sciences Pvt Ltd, India | 16:40-17:00 | Multi-disciplinary approach in signal detection in vaccine trials |
| Pannel Discussions | ||
day 2 agenda
| Day-2 (July 11, 2025) | ||
| Keynote Talks | ||
| Tian Wang,University of Texas Medical Branch, USA | 09:30-10:00 | Development of safe and efficacious vaccines against emerging arboviruses |
| Jerald Sadoff, Centivax Inc, USA | 10:00-10:30 | Universal vaccines against influenza and other pathogens |
| TBA | 10:30-11:00 | Keynote Slot available |
| Refreshment Break (11:00-11:20) | ||
| Technical Session-III | ||
| Session Chairs: TBA | ||
| Stephanie Noviello, University of Florida, USA | 11:20-11:40 | Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus-diphtheria-acellular pertussis vaccine: a randomised, double-blind, phase 2b trial |
| Sergei M. Danilov, University of Illinois at Chicago, USA | 11:40-12:00 | ACE-dependent Alzheimer’s disease |
| Baek Kim, Vernagen LLC, USA | 12:00-12:20 | TBA |
| 12:20-12:40 | Slot available | |
| Yoon-Hee Lee, Animal and Plant Quarantine Agency, South Korea | 12:40-13:00 | The appication of Nano-Luciferase based biosensor for the detection of FMDV(Foot and Mouth Disease Virus) type Asia1 |
| Lunch Break @ Restaurant (13:00-14:00) | ||
| Poster Presentations(14:00-15:00) | ||
| Technical Session-IV | ||
| Session Chairs: TBA | ||
| Vinod Mattoo, DiagnoSearch Life Sciences, India | 15:00-15:20 | Risk based monitoring facilitated by early, real time review of site wise safety trends in vaccine trials |
| Yacob Mathai Kunnathazhath, Marma Health Centre,Kaloor,Kochi, India | 15:20-15:40 | Why is the vaccine life-threatening if people get a fever after a COVID-19 vaccination? |
| Monique Barnard-Matthee, Stellenbosch University, South Africa | 15:40-16:00 | The development and automation of activity assays for enzymes involved in in vitro Transcription used for mRNA vaccine development |
| 16:00-16:20 | Slot available | |
| 16:20-16:40 | Slot available | |
| Award Ceremony | ||
| Day 2 Concludes | ||
| NOTE: This is Tentative program and subject to change | ||
| For more information, Contact @ ryan_cooper@vaccine-congress.org | ||